Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing
Next-generation sequencing (NGS) efforts have established catalogs of mutations relevant to cancer development. However, the clinical utility of this information remains largely unexplored. Here, we present the results of the first eight patients recruited into a clinical whole-genome sequencing (WG...
Main Authors: | Schuh, A, Dreau, H, Knight, SJL, Ridout, K, Mizani, T, Vavoulis, D, Colling, R, Antoniou, P, Kvikstad, EM, Pentony, MM, Hamblin, A, Protheroe, A, Parton, M, Shah, KA, Zsolt, O, Athanasou, N, Hassan, B, Flanagan, AM, Ahmed, A, Winter, S, Harris, A, Tomlinson, I, Popitsch, N, Church, DN, Taylor, JC |
---|---|
Format: | Journal article |
Published: |
Cold Spring Harbor Laboratory Press
2018
|
Similar Items
-
Utility of whole-genome sequencing in the clinical diagnostic of rare inherited anaemias
by: C Camps, et al.
Published: (2018) -
The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom
by: Schwarze, K, et al.
Published: (2019) -
Whole-genome sequencing identifies homozygous BRCA2 deletion guiding treatment in dedifferentiated prostate cancer
by: Purshouse, K, et al.
Published: (2017) -
Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project.
by: Robbe, P, et al.
Published: (2018) -
Clinical‐grade validation of whole genome sequencing reveals robust detection of low‐frequency variants and copy number alterations in CLL
by: Klintman, J, et al.
Published: (2018)